MAYREMZO Trademark

Trademark Overview


On Tuesday, June 8, 2021, a trademark application was filed for MAYREMZO with the United States Patent and Trademark Office. The USPTO has given the MAYREMZO trademark a serial number of 90760607. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, March 29, 2024. This trademark is owned by Alexion Pharmaceuticals, Inc.. The MAYREMZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, neurological, immunological and inflammatory related diseases and disorders, none of the aforementioned goods for or in relation to the treatment of multiple sclerosis
mayremzo

General Information


Serial Number90760607
Word MarkMAYREMZO
Filing DateTuesday, June 8, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, March 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, neurological, immunological and inflammatory related diseases and disorders, none of the aforementioned goods for or in relation to the treatment of multiple sclerosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlexion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameAlexion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Friday, June 11, 2021NEW APPLICATION ENTERED
Saturday, August 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 25, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 25, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, May 16, 2022ASSIGNED TO PETITION STAFF
Friday, May 20, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 22, 2022SOU EXTENSION 1 FILED
Tuesday, November 22, 2022SOU EXTENSION 1 GRANTED
Thursday, November 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 6, 2023SOU TEAS EXTENSION RECEIVED
Saturday, May 6, 2023SOU EXTENSION 2 FILED
Saturday, May 6, 2023SOU EXTENSION 2 GRANTED
Friday, November 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 10, 2023SOU EXTENSION 3 FILED
Friday, November 10, 2023SOU EXTENSION 3 GRANTED
Friday, March 29, 2024SOU EXTENSION 4 FILED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 29, 2024SOU EXTENSION 4 GRANTED